A Study of Novel Combinations in Non-Small Cell Lung Cancer (NSCLC)

PHASE2RecruitingINTERVENTIONAL
Enrollment

278

Participants

Timeline

Start Date

August 7, 2025

Primary Completion Date

March 21, 2027

Study Completion Date

April 6, 2029

Conditions
Non-Small Cell Lung Cancer
Interventions
DRUG

Rilvegostomig

Rilvegostomig will be administered as IV infusion.

DRUG

Ramucirumab

Ramucirumab will be administered as IV infusion.

DRUG

Dato-DXd

Dato-DXd will be administered as IV infusion.

Trial Locations (57)

100

NOT_YET_RECRUITING

Research Site, Taipei

110

NOT_YET_RECRUITING

Research Site, Taipei

736

NOT_YET_RECRUITING

Research Site, Liuying

3722

NOT_YET_RECRUITING

Research Site, Seoul

5011

NOT_YET_RECRUITING

Research Site, Woodville

5505

NOT_YET_RECRUITING

Research Site, Seoul

6009

NOT_YET_RECRUITING

Research Site, Nedlands

10330

NOT_YET_RECRUITING

Research Site, Bangkok

10400

NOT_YET_RECRUITING

Research Site, Bangkok

10700

NOT_YET_RECRUITING

Research Site, Bangkok

11217

NOT_YET_RECRUITING

Research Site, Taipei

13496

NOT_YET_RECRUITING

Research Site, Seongnam-si

16247

NOT_YET_RECRUITING

Research Site, Suwon

16499

NOT_YET_RECRUITING

Research Site, Suwon

21231

NOT_YET_RECRUITING

Research Site, Baltimore

21565

NOT_YET_RECRUITING

Research Site, Namdong-gu

22031

NOT_YET_RECRUITING

Research Site, Fairfax

28644

NOT_YET_RECRUITING

Research Site, Cheongju-si

30318

NOT_YET_RECRUITING

Research Site, Atlanta

40447

NOT_YET_RECRUITING

Research Site, Taichung

70403

NOT_YET_RECRUITING

Research Site, Tainan City

74120

NOT_YET_RECRUITING

Research Site, Banphaeo

77090

NOT_YET_RECRUITING

Research Site, Houston

90404

NOT_YET_RECRUITING

Research Site, Santa Monica

95403

NOT_YET_RECRUITING

Research Site, Santa Rosa

110042

NOT_YET_RECRUITING

Research Site, Shenyang

168583

NOT_YET_RECRUITING

Research Site, Singapore

276001

NOT_YET_RECRUITING

Research Site, Linyi

310014

NOT_YET_RECRUITING

Research Site, Hangzhou

330000

NOT_YET_RECRUITING

Research Site, Nanchang

330006

RECRUITING

Research Site, Nanchang

350014

NOT_YET_RECRUITING

Research Site, Fuzhou

410013

NOT_YET_RECRUITING

Research Site, Changsha

430022

RECRUITING

Research Site, Wuhan

450000

NOT_YET_RECRUITING

Research Site, Zhengzhou

450008

NOT_YET_RECRUITING

Research Site, Zhengzhou

510080

NOT_YET_RECRUITING

Research Site, Guangzhou

510100

RECRUITING

Research Site, Guangzhou

519000

NOT_YET_RECRUITING

Research Site, Zhuhai

523059

NOT_YET_RECRUITING

Research Site, Dongguan

610041

NOT_YET_RECRUITING

Research Site, Chengdu

618000

NOT_YET_RECRUITING

Research Site, Deyang

621000

RECRUITING

Research Site, Mianyang

M5G 2M9

NOT_YET_RECRUITING

Research Site, Toronto

Unknown

RECRUITING

Research Site, Shantou

113-8677

NOT_YET_RECRUITING

Research Site, Bunkyō City

650-0047

NOT_YET_RECRUITING

Research Site, Kobe

830-0011

NOT_YET_RECRUITING

Research Site, Kurume-shi

606-8507

NOT_YET_RECRUITING

Research Site, Kyoto

541-8567

NOT_YET_RECRUITING

Research Site, Osaka

591-8555

NOT_YET_RECRUITING

Research Site, Sakaishi

162-8655

NOT_YET_RECRUITING

Research Site, Shinjuku-ku

641-8510

NOT_YET_RECRUITING

Research Site, Wakayama

236-0051

NOT_YET_RECRUITING

Research Site, Yokohama

03080

NOT_YET_RECRUITING

Research Site, Seoul

06351

NOT_YET_RECRUITING

Research Site, Seoul

00333

NOT_YET_RECRUITING

Research Site, Taoyuan District

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Daiichi Sankyo

INDUSTRY

lead

AstraZeneca

INDUSTRY

NCT07098338 - A Study of Novel Combinations in Non-Small Cell Lung Cancer (NSCLC) | Biotech Hunter | Biotech Hunter